131 related articles for article (PubMed ID: 25478777)
1. Evidence-based integration of selective internal radiation therapy into the management of breast cancer liver metastases.
Cianni R; Pelle G
Future Oncol; 2014 Nov; 10(15 Suppl):93-5. PubMed ID: 25478777
[No Abstract] [Full Text] [Related]
2. Evidence-based integration of selective internal radiation therapy into the management of ocular melanoma liver metastases.
Stedman B
Future Oncol; 2014 Nov; 10(15 Suppl):97-100. PubMed ID: 25478778
[No Abstract] [Full Text] [Related]
3. Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases.
Wasan HS
Future Oncol; 2014 Nov; 10(15 Suppl):33-6. PubMed ID: 25478764
[No Abstract] [Full Text] [Related]
4. Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management.
Sangro B
Future Oncol; 2014 Nov; 10(15 Suppl):7-11. PubMed ID: 25478760
[No Abstract] [Full Text] [Related]
5. Radioembolization in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
[TBL] [Abstract][Full Text] [Related]
6. Ongoing selective internal radiation therapy-based studies in the treatment of liver-dominant metastatic colorectal cancer.
Heinemann V
Future Oncol; 2014 Nov; 10(15 Suppl):37-9. PubMed ID: 25478765
[No Abstract] [Full Text] [Related]
7. Y90 selective internal radiation therapy.
Lee EW; Thakor AS; Tafti BA; Liu DM
Surg Oncol Clin N Am; 2015 Jan; 24(1):167-85. PubMed ID: 25444474
[TBL] [Abstract][Full Text] [Related]
8. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).
Sangro B
Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769
[No Abstract] [Full Text] [Related]
9. Selective internal radiation therapy dosimetry.
Kennedy A
Future Oncol; 2014 Nov; 10(15 Suppl):77-81. PubMed ID: 25478774
[No Abstract] [Full Text] [Related]
10. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
[TBL] [Abstract][Full Text] [Related]
11. Gastroduodenal ulceration after selective internal radiation therapy of liver tumor.
Wallstabe I; Bakos G; Plötner A; Kretzschmar A; Wegner D; Hohdorf K; Scheibe J
Endoscopy; 2012; 44 Suppl 2 UCTN():E354-5. PubMed ID: 23012018
[No Abstract] [Full Text] [Related]
12. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
13. The evidence for resection post-selective internal radiation therapy.
Garlipp B; Bruns CJ
Future Oncol; 2014 Nov; 10(15 Suppl):49-52. PubMed ID: 25478767
[No Abstract] [Full Text] [Related]
14. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.
Saxena A; Kapoor J; Meteling B; Morris DL; Bester L
Ann Surg Oncol; 2014 Apr; 21(4):1296-303. PubMed ID: 24337647
[TBL] [Abstract][Full Text] [Related]
15. The safety of resection post-selective internal radiation therapy.
Rotellar F; Pardo F; Martínez-Ortega P
Future Oncol; 2014 Nov; 10(15 Suppl):53-5. PubMed ID: 25478768
[No Abstract] [Full Text] [Related]
16. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
[TBL] [Abstract][Full Text] [Related]
17. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Welsh JS; Kennedy AS; Thomadsen B
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
[TBL] [Abstract][Full Text] [Related]
18. Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance.
Paprottka PM; Schmidt GP; Trumm CG; Hoffmann RT; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):964-72. PubMed ID: 21748452
[TBL] [Abstract][Full Text] [Related]
19. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
Gulec SA; Fong Y
Arch Surg; 2007 Jul; 142(7):675-82. PubMed ID: 17638807
[TBL] [Abstract][Full Text] [Related]
20. [Selective internal radiotherapy for advanced liver tumors and metastases].
Hoffmann RT; Jakobs TF; Tatsch K; Reiser MF
Dtsch Med Wochenschr; 2008 Oct; 133(41):2099-102. PubMed ID: 18814106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
